C3 Glomerulopathy Clinical Trials in Sapporo, Hokkaido
2 recruitingSapporo, Hokkaido, Japan
Showing 1–2 of 2 trials
Recruiting
Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
C3 GlomerulopathyImmune-complex-membranoproliferative Glomerulonephritis
Novartis Pharmaceuticals225 enrolled50 locationsNCT03955445
Recruiting
Fabhalta Capsules Specified Drug-use Survey
C3 Glomerulopathy
Novartis Pharmaceuticals50 enrolled26 locationsNCT07156149